Goldman Sachs
HIMS icon

Goldman Sachs’s Hims & Hers Health HIMS Stock Holding History

Goldman Sachs’s Portfolio HIMS Stock Details HIMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$179M Buy
5,173,865
+2,719,170
+111% +$73M 0.02% 829
2026
Q1 		$51M Sell
2,454,695
-7,892,648
-76% -$186M 0.01% 1568
2025
Q4 		$336M Buy
10,347,343
+1,123,832
+12% +$48.1M 0.04% 431
2025
Q3 		$523M Buy
9,223,511
+1,060,497
+13% +$54.3M 0.06% 287
2025
Q2 		$407M Buy
8,163,014
+2,845
+0% +$129K 0.06% 341
2025
Q1 		$241M Buy
8,160,169
+2,616,501
+47% +$97.2M 0.04% 450
2024
Q4 		$134M Buy
5,543,668
+4,488,389
+425% +$111M 0.02% 665
2024
Q3 		$19.4M Sell
1,055,279
-1,176,243
-53% -$21.1M ﹤0.01% 2100
2024
Q2 		$45.1M Buy
2,231,522
+484,774
+28% +$8.07M 0.01% 1237
2024
Q1 		$27M Buy
1,746,748
+523,660
+43% +$5.9M ﹤0.01% 1590
2023
Q4 		$10.9M Sell
1,223,088
-1,230,601
-50% -$9.1M ﹤0.01% 2449
2023
Q3 		$15.4M Buy
2,453,689
+312,023
+15% +$2.32M ﹤0.01% 2014
2023
Q2 		$20.1M Buy
2,141,666
+655,281
+44% +$6.5M ﹤0.01% 1844
2023
Q1 		$14.7M Buy
1,486,385
+807,028
+119% +$7.07M ﹤0.01% 2071
2022
Q4 		$4.35M Buy
679,357
+465,929
+218% +$2.65M ﹤0.01% 3294
2022
Q3 		$1.19M Buy
213,428
+147,835
+225% +$891K ﹤0.01% 4388
2022
Q2 		$297K Sell
65,593
-59,309
-47% -$253K ﹤0.01% 5429
2022
Q1 		$666K Buy
124,902
+2,689
+2% +$13.3K ﹤0.01% 5139
2021
Q4 		$800K Sell
122,213
-402,331
-77% -$2.91M ﹤0.01% 5036
2021
Q3 		$3.96M Buy
524,544
+473,069
+919% +$4.01M ﹤0.01% 3560
2021
Q2 		$561K Sell
51,475
-104,574
-67% -$1.24M ﹤0.01% 5147
2021
Q1 		$2.06M Buy
+156,049
New +$2.62M ﹤0.01% 3948

Other funds holding HIMS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DSCM
Divisadero Street Capital Management Miami, Florida $4.41B AUM 90.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Goldman Sachs's HIMS Position: Q2 2026 in Review

Goldman Sachs increased its Hims & Hers Health (HIMS) stake by 111% in Q2 2026, buying an estimated $73M and bringing the position to 5,173,865 shares worth $179M. The position accounts for 0.02% of the portfolio, ranked #829.

Goldman Sachs first reported a position in HIMS in Q1 2021 and has held it in 22 quarters since. The position peaked at $523M in Q3 2025. 506 funds tracked by Wall St. Rank hold HIMS as of Q2 2026.

  • Goldman Sachs held 5,173,865 shares of Hims & Hers Health worth $179M as of Q2 2026.
  • Goldman Sachs bought 2,719,170 Hims & Hers Health shares in Q2 2026, an estimated $73M.
  • Hims & Hers Health made up 0.02% of Goldman Sachs's portfolio in Q2 2026, its #829 holding.
  • Goldman Sachs first reported a position in Hims & Hers Health in Q1 2021 and has held it in 22 quarters since.
  • Goldman Sachs's Hims & Hers Health position peaked at $523M in Q3 2025.
  • 506 funds tracked by Wall St. Rank held Hims & Hers Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.